Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Innovative Medical |
---|---|
Information provided by: | Innovative Medical |
ClinicalTrials.gov Identifier: | NCT00469573 |
The purpose of this study is to determine if Optive®eye drops are safe for people who wear contact lenses and have dry eyes. The second goal of the study is to determine if using Optive®eye drops can improve my dry eye scores on a standard dry eye test (called the OSDI).
Condition | Intervention | Phase |
---|---|---|
Dry Eye |
Drug: 1. Optive |
Phase IV |
Study Type: | Interventional |
Study Design: | Non-Randomized, Open Label, Single Group Assignment |
Official Title: | Safety and Efficacy of Optive in Contact Lens Wearers With Dry Eyes |
Enrollment: | 36 |
Study Start Date: | May 2007 |
Study Completion Date: | March 2008 |
Primary Completion Date: | March 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1. |
Drug: 1. Optive
Optive 15ml- (in the eye) Instill one drop twice daily in each eye
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Men and women 18 and over
Exclusion Criteria:
Use of RGP or PMMA contact lenses
Use of systemic medications with ocular drying sequelae:
Responsible Party: | South Shore Eye Care ( Jodi Luchs, MD ) |
Study ID Numbers: | 5302 |
Study First Received: | May 2, 2007 |
Last Updated: | March 31, 2008 |
ClinicalTrials.gov Identifier: | NCT00469573 History of Changes |
Health Authority: | United States: Institutional Review Board |